Stock Research

Royal Challengers Bengaluru, one of the most-loved cricket teams in the Indian Premier League (IPL), has a new owner. In a landmark transaction that values the IPL franchise at $1.78 billion, RCB was sold to a consortium led by the Aditya Birla Group, and include sports investor David Blitzer and private equity firm Blackstone. The… Continue reading RCB sold for $1.78B in India’s blockbuster IPL franchise deal

OpenAI is closing down its video generation platform Sora just months after its launch, marking a sharp shift in priorities at the company behind ChatGPT. The move comes as OpenAI pivots away from consumer-facing video tools and towards longer-term bets such as robotics and enterprise-focused artificial intelligence. The decision was communicated internally by CEO Sam… Continue reading Why is OpenAI shutting down Sora just months after launch?

US equities pulled back on Tuesday, giving up part of the previous session’s gains as rising oil prices and uncertainty around the ongoing Iran conflict weighed on investor sentiment.  Markets struggled to find direction amid conflicting signals on diplomacy and escalating geopolitical risks, while higher Treasury yields added further pressure. The S&P 500 fell 0.37%… Continue reading S&P 500, Dow Jones dip as Iran tensions cloud outlook

On Tuesday, Bitcoin saw a pullback while crypto-related stocks saw a decline.  Arm announced a move to in-house AI chip production while Jamie Dimon warned about AI-driven job losses in the US.  Bitcoin slips amid risk-off sentiment Bitcoin drifted lower on Tuesday, slipping back toward the $69,000 level as broader weakness in equities spilled over… Continue reading Evening digest: Bitcoin dips, Jamie Dimon warns on AI job risks

ImmunityBio Inc (NASDAQ: IBRX) is under immense pressure on March 24 after the US Food and Drug Administration (FDA) issued a scathing warning letter over the firm’s promotional tactics. Investors bailed on IBRX as regulators alleged the company and its billionaire founder, Dr. Patrick Soon-Shiong, used a TV ad and a high-profile podcast to make… Continue reading ImmunityBio stock price crash: buy the dip or sell the rip?

Arm Holdings on Tuesday announced plans to design and sell its first in-house silicon product, marking a significant shift from its decades-long business model centred on licensing chip designs. The new processor, called the AGI CPU, is aimed at powering artificial intelligence workloads in data centres and is expected to open up a multi-billion-dollar revenue… Continue reading Arm pivots to chipmaking with AI chip launch: what this could mean for ARM

Shares of Corning surged more than 9% on Tuesday, as a bullish analyst note and optimism around artificial intelligence demand lifted investor sentiment. The glassmaker’s shares were trading at $143.38, up 9.5% from Monday’s close at the time of writing. The stock has already posted strong gains in 2026, rising more than 60% year to… Continue reading Corning stock jumps 9% as AI demand, analyst boost lift outlook

Estée Lauder and Puig have confirmed they are in discussions over a potential merger that could create a luxury beauty group with a combined market capitalisation of around $40 billion, bringing together a portfolio of global brands spanning skincare, cosmetics, and fragrances. The companies said on March 23 that talks are ongoing, confirming earlier media… Continue reading Why is Estée Lauder’s stock falling on talks of merger with Spain’s Puig?

Volkswagen is in discussions with Rafael Advanced Defence Systems over a potential agreement to convert one of its German factories to produce missile defence components, the Financial Times reported, citing people familiar with the discussions. The proposed partnership would involve repurposing Volkswagen’s Osnabrück plant in Lower Saxony to manufacture parts for Israel’s Iron Dome air… Continue reading Volkswagen in talks to convert German plant for missile defence production